D 0112 005
Alternative Names: D-0112-005Latest Information Update: 29 Jul 2024
At a glance
- Originator Easton Biopharmaceuticals
- Class Antineoplastics
- Mechanism of Action Poly(ADP-ribose) polymerase-1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer